Mark Marlow is listed as a director on 3 SEC Form D filings by 3 issuers between Jul 2012 and Mar 2022: NAIKU INC (Minnetonka, MN — other technology — 2014; $1.02M reported sold to 11 investors), Stratix Labs Corp (St. Paul, MN — biotechnology — 2022; $786K reported sold to 9 investors) and Bavia Health, Inc. (Edina, MN — other health care — 2012; $528K reported sold to 14 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 10 years. Across those companies the filings report $2.33M sold in total.
Listed alongside Adisack Nhouyvanisvong (1 shared filing), Charles Kyte (1 shared filing), Greg Wright (1 shared filing), John Alexander (1 shared filing), Josh Erickson (1 shared filing) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Mark Marlow and found 5 differences, 1 worth asking the sponsor about: Form D filed 70 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.